Modern therapy concepts for endometrial cancer;Moderne Konzepte in der Behandlung des Endometriumkarzinoms

Pathologe

Volumn 30, Issue 4, 2009, Pages 268-273

  Emons, G ^a   Hellriegel, M ^a   Hawighorst, T ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Chemotherapy; Endocrine therapy; Endometrial cancer; Radiotherapy; Surgical therapy

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADJUVANT CHEMOTHERAPY; BRACHYTHERAPY; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CLEAR CELL CARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; LAPAROSCOPY; METASTASIS; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTMENOPAUSE; PROGNOSIS; REVIEW; SALPINGOOOPHORECTOMY;

ADULT; BRACHYTHERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYPERPLASIA; MIDDLE AGED; NEOPLASM STAGING; PERIMENOPAUSE; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 68149161800     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-009-1149-9     Document Type: Review

References (29)

1. Aalders JG, Thomas G (2006) Endometrial cancer-Revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol 104:222-231
2. Amant F, Moerman P, Neven P et al (2007) Treat-ment modalities in endometrial cancer. Curr Opin Oncol 19:479-485
3. Benedetti Panici P, Basile S, Maneschi F et al (2008) Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcino-ma: Randomized clinical trial. J Natl Cancer Inst 100:1707-1716
4. Carey MS, Gawlik C, Fung-Kee-Fung M et al on be-half of the Cancer Care Ontario Practice Guidelines Initiative Gynecology Cancer Disease Site Group (2006) Systematic review of systematic therapy for advanced or recurrent endometrial cancer. Gyne-col Oncol 101:158-167
5. Chan JK, Kapp DS (2007) Role of complete lymph-adenectomy in endometrioid uterine cancer. Lan-cet Oncol 8:831-841
6. Chan JK, Wu H, Cheung MK et al (2007) The outco-mes of 27,063 women with unstaged endometrio-id uterine cancer. Gynecol Oncol 106:282-288
7. Creutzberg CL, van Putten WU, Wárlám-Rodenhuis CC et al (2004) Outcome of high-risk stage IC, gra-de 3, compared with stage I endometrial carcino-ma patiens: the Postoperative radiation therapy in endometrial carcinoma trial. J Clin Oncol 22:1234-1241
8. Emons G (2007) Endometriumkarzinom. Frauen-heilkunde up2date1:35-45
9. Emons G, Günthert A,ViereckV, Hanf V (2003) En-dokrine Therapie des Endometriumkarzinoms und seiner Präkanzerosen. Gynäkologe 36:86-96
10. Geisler JP, Linnemeier GC, Manahan KJ (2007) Pel-vic and para-aortic lymphadenectomy in patients with endometrioid adenocarcinoma of the endo-metrium. Int J Gynecol Obstet 98:39-43
11. Hanf V, Günthert AR, Emons G (2003) Endometrial Cancer. Onkologie 26:429-436
12. Humber C, Tierney J, Symonds P et al (2005) Che-motherapy for advanced, recurrent or metastatic endometrial carcinoma. The Cochrane database of systematic reviews, Issue 4. Art. No.: CD003915. pub3. DOI: 10.1002/14651858. CD003915.pub3
13. Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e. V. in der Deutschen Ge-sellschaft für Gynäkologie und Geburtshilfe e.V. sowie in der Deutschen Krebsgesellschaft e.V. (2008) Interdisziplinäre S2k-Leitlinie für die Dia-gnostik und Therapie des Endometriumkarzinoms. In: Kommission Uterus der Arbeitsgemeinschaft Gynäkologische Onkologie e.V., Deutsche Ge-sellschaft für Gynäkologie und Geburtshilfe e. V., Deutsche Krebsgesellschaft e.V. (Hrsg) Leitlinien zum Zervixkarzinom, zum Endometriumkarzinom und zu den Trophoblasttumoren. Zuckschwerdt, München Wien New York, S 73-126
14. Kong A, Johnson N, Cornes P et al (2007) Adjuvant radiotherapy for stage I endometrial cancer. Cochrane database of systematic reviews, Issue 2. Art. No.: CD003916. DOI: 10.1002/1465858. CD 003916.pub2
15. (2008) Krebs in Deutschland 2003 - 2004. Häufig-keiten und Trends. 6. überarbeitete Auflage. Ro-bert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg). Berlin
16. KresowikJ, Ryan GL, Van Voorhis BJ (2008) Progression of atypical endometrial hyperplasia to ade-nocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intra-uterine system. Obstet Gynecol 111:547-549
17. Lin LL, Mutch DG, Rader JS et al (2007) External ra-diotherapy versus vaginal brachytherapy for pa-tients with intermediate risk endometrial cancer. Gynecol Oncol 106:215-220
18. Maggi R, Lissoni A, Spina F et al (2006) Adjuvant chemotherapy vs radiotherapy in high-risk endo-metrial carcinoma: results of a randomised trial. Br J Cancer 95:266-271
19. Mariani A, Dowdy SC, Cliby WA et al (2008) Pro-spective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging. Gynecol Oncol 109:11-18
20. Palomba S, Falbo A, Mocciaro R et al (2009) Lapa-roscopic treatment for endometrial cancer: a me-ta-analysis of randomized controlled trials (RCTs). Gynecol Oncol 112:415-421
21. Rackow BW, Arid A (2006) Endometrial cancer and fertility. Curr Opin Obstet Gynecol 18:245-252
22. Ramirez PT, Frumovitz M, Bodurka DC et al (2004) Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 95:133-138
23. Randall ME, Filiaci VL, Muss H et al (2006) Rando-mized phase III trial of whole-abdominal irradiati-on versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecolo-gic Oncology Group study. J Clin Oncol 24:36-44
24. Signorelli M, Caspani G, Bonazzi C et al (2009) Fer-tility-sparing treatment In young women with en-dometrial cancer or atypical complex hyperpla-sia: a prospective single-institution experience of 21 cases. BJOG: lnt J Obstetrics Gynaecol 116:114-118
25. Smith DC, Macdonald OK, Lee CM, Gaffney DK (2007) Survival impact of lymph node dissection in endometrial adenocarcinoma: a surveillance, epi-demiology and end results analysis, lnt J Gynecol Cancer 18:255-261
26. Susumu N, Sagae S, Udagawa Y et al (2008) Ran-domized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate - and high-risk endo-metrial cancer: a Japanese gynaecologic oncology group study. Gynecol Oncol 108:226-233
27. The ASTEC/EN.5 writing committee on behalf of the ASTEC/EN.5 Study Group (2009) Adjuvant ex-ternal beam radiotherapy in the treatment of en-dometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review and meta-analysis. Lancet 373:137-146
28. The writing committee on behalf of the ASTEC study group (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373:125-136
29. Trimble CL, Kauderer J, Zaino R et al (2006) Con-current endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia. A Gynecologic Oncology Group Study. Cancer 106:812-819